Lantus Solostar



Indications and Reactions:

Role Indications Reactions
Primary
Type 2 Diabetes Mellitus 62.3%
Diabetes Mellitus 14.4%
Device Therapy 5.7%
Type 1 Diabetes Mellitus 5.2%
Type Ii Diabetes Mellitus 3.8%
Hypertension 2.2%
Product Used For Unknown Indication 1.9%
Diabetes 0.9%
Blood Pressure 0.9%
Cardiac Disorder 0.5%
Blood Cholesterol 0.4%
Type I Diabetes Mellitus 0.4%
Anticoagulant Therapy 0.2%
Depression 0.2%
Dyslipidaemia 0.2%
Blood Cholesterol Abnormal 0.2%
Prophylaxis 0.2%
Anxiety 0.1%
Asthma 0.1%
Blood Glucose Increased 0.1%
Visual Impairment 17.9%
Visual Acuity Reduced 12.8%
Weight Decreased 8.8%
Malaise 6.1%
Weight Increased 5.2%
Tremor 4.7%
Death 4.6%
Vision Blurred 4.3%
Myocardial Infarction 4.2%
Injection Site Pain 3.9%
Cerebrovascular Accident 3.1%
Nasopharyngitis 3.1%
Renal Failure 3.0%
Cataract 2.7%
Device Malfunction 2.7%
Pneumonia 2.7%
Vomiting 2.6%
Hypoglycaemia 2.5%
Injury Associated With Device 2.5%
Hospitalisation 2.4%
Secondary
Type 2 Diabetes Mellitus 63.4%
Diabetes Mellitus 10.2%
Type 1 Diabetes Mellitus 8.1%
Device Therapy 7.0%
Type Ii Diabetes Mellitus 3.2%
Product Used For Unknown Indication 1.5%
Hypertension 1.3%
Blood Pressure 0.9%
Diabetes 0.9%
Suicide Attempt 0.6%
Cardiac Disorder 0.4%
Type I Diabetes Mellitus 0.4%
Blood Cholesterol Abnormal 0.3%
Pain 0.3%
Blood Cholesterol 0.3%
Rash 0.2%
Blood Pressure High 0.2%
Cerebrovascular Accident Prophylaxis 0.2%
Cholesterol 0.2%
Coagulation Disorder 0.2%
Injury Associated With Device 15.2%
Visual Acuity Reduced 13.1%
Visual Impairment 11.4%
Weight Decreased 9.3%
Tremor 5.5%
Vomiting 5.2%
Vision Blurred 4.7%
Hypoglycaemia 4.4%
Injection Site Pain 3.8%
Malaise 3.8%
Pain 2.9%
Renal Disorder 2.9%
Weight Increased 2.9%
Nausea 2.3%
Penile Necrosis 2.3%
Suicide Attempt 2.3%
Blood Glucose Increased 2.0%
Incorrect Storage Of Drug 2.0%
Wrong Drug Administered 2.0%
Dizziness 1.7%
Concomitant
Product Used For Unknown Indication 41.3%
Diabetes Mellitus 13.6%
Fluid Replacement 8.2%
Type 2 Diabetes Mellitus 6.4%
Drug Use For Unknown Indication 5.8%
Rheumatoid Arthritis 3.3%
Hypertension 2.5%
Plasma Cell Myeloma 2.5%
Back Pain 1.8%
Anxiety 1.6%
Atrial Fibrillation 1.6%
Neuropathy Peripheral 1.6%
Type 1 Diabetes Mellitus 1.6%
Essential Hypertension 1.5%
Depression 1.3%
Cardiac Disorder 1.1%
Multiple Sclerosis 1.1%
Renal Cancer 1.1%
Sciatica 1.1%
Erectile Dysfunction 0.9%
Pain 11.1%
Death 9.3%
Urinary Tract Infection 7.4%
Vomiting 7.4%
Nausea 5.6%
Rash 5.6%
Rheumatoid Arthritis 5.6%
Diarrhoea 3.7%
Drug Ineffective 3.7%
Malaise 3.7%
Myocardial Infarction 3.7%
Overdose 3.7%
Pain In Extremity 3.7%
Plasma Cell Myeloma 3.7%
Pneumonia 3.7%
Red Blood Cell Count Decreased 3.7%
Renal Failure Chronic 3.7%
Respiratory Failure 3.7%
Thrombosis 3.7%
Type 2 Diabetes Mellitus 3.7%
Interacting
Type 2 Diabetes Mellitus 80.0%
Hypertension 20.0%
Drug Interaction 100.0%